Strong Growth Potential Could Lift These 2 AI-Related Stocks Higher, Says Stifel
The race for AI supremacy has taken an unexpected twist as Chinese AI startup DeepSeek’s latest AI model, which is both ...
Stifel maintains Buy on Bicara stock with $47 target
Stifel analysts reiterated a Buy rating on Bicara Therapeutics Inc (NASDAQ:BCAX), maintaining a $47.00 price target. Trading ...
Stifel maintains Buy on MaxLinear, keeps $26 target
Stifel analysts maintained a positive outlook on MaxLinear shares (NASDAQ:MXL), reiterating a Buy rating and a price target ...
Stifel Nicolaus Keeps Their Buy Rating on Starbucks (SBUX)
In a report released yesterday, Chris O`Cull from Stifel Nicolaus maintained a Buy rating on Starbucks (SBUX – Research Report), with a price ...
Diversified Expands Asset Base, Density, and Commodity Mix with Acquisition of Liquids Rich Maverick Natural Resources
Financial and Strategic Accretive Acquisition Provides Opportunity for 95% Increase in Revenue, Enhanced Margins, Expense Synergies, and 55% Increase in Free Cash Flow ...